Jazz Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,268	4,069	3,834	3,659	3,094
Revenue Growth (YoY)	4.88%	6.12%	4.78%	18.26%	30.91%
Cost of Revenue	503.3	445.71	435.58	540.52	440.76
Gross Profit	3,764	3,623	3,399	3,119	2,653
Selling, General & Admin	1,809	1,385	1,343	1,417	1,452
Depreciation & Amortization Expenses	654.66	627.31	608.28	599.17	525.77
Research & Development	782.74	884	849.66	590.45	505.75
Other Operating Expenses	947.86	10	19	577.8	-
Total Operating Expenses	4,195	2,907	2,820	3,184	2,483
Operating Income	-430.24	716.63	578.58	-65.53	170.28
Interest Expense	-195.05	-238.1	-289.44	-288.24	-278.77
Other Non-Operating Income (Expense)	-3.3	-9.84	5.78	-28.94	-5.06
Total Non-Operating Income (Expense)	-198.35	-247.94	-283.66	-317.18	-283.83
Pretax Income	-627.86	470.35	297.93	-372.78	-112.84
Provision for Income Taxes	-272.44	-91.43	-119.91	-158.65	216.12
Net Income	-356.15	560.12	414.83	-224.06	-329.67
Net Income to Common	-356.15	560.12	414.83	-224.06	-329.67
Net Income Growth	-	35.02%	-	-	-
Shares Outstanding (Basic)	61	62	63	63	60
Shares Outstanding (Diluted)	61	66	72	63	60
Shares Change (YoY)	-7.61%	-8.41%	15.23%	4.77%	5.62%
EPS (Basic)	-5.84	9.06	6.55	-3.58	-5.52
EPS (Diluted)	-5.84	8.65	6.10	-3.58	-5.52
EPS Growth	-	41.80%	-	-	-
Free Cash Flow	1,297	1,358	1,068	1,243	750.87
Free Cash Flow Growth	-4.48%	27.13%	-14.07%	65.53%	-15.12%
Free Cash Flow Per Share	21.27	20.57	14.82	19.87	12.58
Gross Margin	88.21%	89.05%	88.64%	85.23%	85.76%
Operating Margin	-10.08%	17.61%	15.09%	-1.79%	5.50%
Profit Margin	-8.35%	13.77%	10.82%	-6.12%	-10.65%
FCF Margin	30.39%	33.37%	27.86%	33.97%	24.27%
EBITDA	266.06	1,377	1,217	563.94	722.76
EBITDA Margin	6.23%	33.83%	31.75%	15.41%	23.36%
EBIT	-430.24	716.63	578.58	-65.53	170.28
EBIT Margin	-10.08%	17.61%	15.09%	-1.79%	5.50%
Effective Tax Rate	43.39%	-19.44%	-40.25%	42.56%	-191.53%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q